🟢 Protara Therapeutics is trading 6% up in pre-market

Protara Therapeutics is trading at $3.44, up +5.85%, with no clear reason identified for the September 29, 2026 pre-market gain.

• No company-specific announcement or clearly linked catalyst surfaced in available coverage.
• The latest identified company announcement was a September 8 conference-presentation notice, which predates the move.
• Coverage lists older clinical-trial updates and financial results; available evidence does not establish a sector-wide or broader-market explanation.